Taaleri invests in Nordtreat, a company producing environmentally friendly and non-toxic fire retardants
TAALERI PLC PRESS RELEASE 9 MARCH 2022 AT 9:15 (EET)
Taaleri invests in Nordtreat, a company producing environmentally friendly and non-toxic fire retardants
Taaleri invests EUR 1.0 million in Nordtreat, a Finnish company producing environmentally friendly and non-toxic fire retardants. Nordtreat raised a total of EUR 4 million in its latest financing round, which will help the company accelerate its international growth, expand its product portfolio and develop its production at the company's plant in Vantaa.
Founded in 2015, Nordtreat manufactures e.g. fire retardant chemicals based on non-toxic bio-based acids for building materials made from renewable raw materials. The company has developed and commercialized fire retardants, especially for wood construction. The products are based on the company's patented fire protection technology. Nordtreat's products replace traditional fire retardants that contain compounds that are harmful to humans and the environment, such as boric acid, formaldehyde, and ammonia.
The investment in Nordtreat opens up investment opportunities for the Taaleri Bioindustry I fund, which is in the fundraising phase. The fund was launched last December and was one of Finland's first private equity funds to be classified as dark green, i.e. funds under Article 9 of the EU Sustainable Finance Disclosure Regulation. The fund only makes sustainable investments in projects that, for example, contribute substantially to climate change mitigation.
“We are very pleased that Taaleri was given the opportunity to participate in Nordtreat’s private placement. The company is set to be one of the first investment targets for our bioindustry fund, and we see great potential for its international growth. We believe that the demand for sustainable fire retardants will increase in the international construction product industry as the sustainability requirements of developers become stricter,” says Tero Saarno, Director of Taaleri Bioindustry.
“We are very pleased with Taaleri's decision to support our growth. The placement enables sustainable investments that many traditional investors are not yet ready for. We believe that Taaleri Bioindustry's expertise will be of considerable benefit to us both in future production plant investments and in terms of sustainability issues,” says Aki Borgentrop, CEO of Nordtreat.
Taaleri Group’s vision is to be a Nordic forerunner in alternative investments focusing on sustainability. Through our private equity funds, we create, for example, wind and solar power and affordable rental homes.
For further information, please contact:
Tero Saarno, Director, Taaleri Bioindustry, +358 50 373 1923, tero.saarno@taaleri.com
Aki Borgentrop, CEO, Nordtreat, +358 400 366 801
Taaleri in brief
Taaleri is a Nordic investment and asset manager with an emphasis on renewable energy and other alternative investments. We channel capital towards economically profitable undertakings that have a lasting positive impact on the environment and society. We are a signatory of the UN Principles for Responsible Investment (UNPRI) since 2010, and we joined the Net Zero Asset Managers initiative in 2021. Taaleri’s vision is to be a Nordic forerunner in alternative investments focusing on sustainability.
Taaleri has two business segments: Private Asset Management and Strategic Investments. Private Asset Management consists of renewable energy, real estate, bioindustry and infrastructure businesses. The Strategic Investments segment includes Garantia Insurance Company Ltd.
Taaleri has EUR 2.2 bn of assets under management in its private equity funds and co-investments. The company has approximately 120 employees. Taaleri Plc is listed on Nasdaq Helsinki.
Nordtreat in brief
Founded in 2015, Nordtreat is a growth company in chemical industry specializing in the manufacture of non-toxic fire retardants. Nordtreat's patented technology is used in the fire protection of building materials made from renewable materials, especially in the construction of public and apartment buildings.
The company employs a total of 22 people in Finland, France, Germany, and Poland, and operates its own plant in Vantaa.
Siri Markula, Head of Communications and IR, tel. +358 40 743 2177, siri.markula@taaleri.com
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
About Taaleri Bioteollisuus
Subscribe to releases from Taaleri Bioteollisuus
Subscribe to all the latest releases from Taaleri Bioteollisuus by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Taaleri Bioteollisuus
Taaleri’s bioindustry fund invests in Nordic Bioproducts Group, a company producing cellulose-based materials with a high processing value30.3.2023 09:15:00 EEST | Press release
TAALERI BIOINDUSTRY PRESS RELEASE 30 MARCH 2023 AT 9:15 (EEST) Taaleri’s bioindustry fund invests in Nordic Bioproducts Group, a company producing cellulose-based materials with a high processing value Taaleri’s bioindustry fund invests in Nordic Bioproducts Group, a Finnish company producing cellulose-based materials with a high processing value. The purpose of the investment is to strengthen Nordic Bioproducts Groups’s (NBG) growth and expansion. Nordic Bioproducts Group was founded in 2019 to develop new biomaterials based on the patented AaltoCell technology. The cellulose hybrids developed and manufactured by NBG are processed from Finnish forest fibres and cellulose-containing industrial and agricultural side and waste streams. The company aims to bring to the market environmentally more sustainable and low-emissions alternatives to fossil raw materials and harmful chemicals. For example, in the textile industry, pulp-based fibres can replace cotton and artificial fibres, and in
Taalerin bioteollisuusrahasto sijoittaa korkean jalostusarvon selluloosapohjaisia materiaaleja valmistavaan Nordic Bioproducts Groupiin30.3.2023 09:15:00 EEST | Tiedote
TAALERI BIOTEOLLISUUS LEHDISTÖTIEDOTE 30.3.2023 klo 9.15 Taalerin bioteollisuusrahasto sijoittaa korkean jalostusarvon selluloosapohjaisia materiaaleja valmistavaan Nordic Bioproducts Groupiin Taalerin bioteollisuuteen keskittyvä rahasto Taaleri Bioteollisuus I sijoittaa suomalaiseen korkean jalostusarvon selluloosapohjaisia materiaaleja valmistavaan Nordic Bioproducts Groupiin. Sijoituksella on tarkoitus vahvistaa Nordic Bioproducts Groupin (NBG) kasvua ja laajentumista. Nordic Bioproducts Group perustettiin vuonna 2019 kehittämään uusia biomateriaaleja, jotka perustuvat patentoituun AaltoCell-teknologiaan. NBG:n kehittämät ja valmistamat selluloosahybridit on jalostettu kotimaisista metsäkuiduista sekä selluloosaa sisältävistä teollisuuden ja maatalouden sivu- ja jätevirroista. Yhtiö pyrkii tuomaan markkinoille ympäristön kannalta kestävämpiä ja vähäpäästöisempiä vaihtoehtoja fossiilisille raaka-aineille ja haitallisille kemikaaleille. Esimerkiksi tekstiiliteollisuudessa sellupohjais
Taaleri’s first bioindustry fund invests in Nordtreat, a company producing bio-based flame retardants22.11.2022 09:15:00 EET | Press release
TAALERI BIOINDUSTRY PRESS RELEASE 22 NOVEMBER 2022 AT 9:15 (EET) Taaleri’s first bioindustry fund invests in Nordtreat, a company producing bio-based flame retardants Taaleri’s first bioindustry fund invests in Nordtreat, a Finnish company producing bio-based, environmentally friendly and non-harmful flame-retardants. The purpose of the investment is to strengthen Nordtreat's growth and expansion. Founded in 2015, Nordtreat manufactures bio-based flame-retardant chemicals for building materials made from renewable raw materials. The company has developed and commercialized fire retardants, especially for wood construction. The products are based on the company's patented fire protection technology. Nordtreat's products replace traditional flame-retardants that contain compounds that are harmful to humans and the environment, such as boric acid, formaldehyde, and ammonia. The investment is Taaleri Bioindustry I Fund’s second investment. The fund invests in industrial-scale production fa
Taalerin ensimmäinen bioteollisuusrahasto sijoittaa biopohjaisia palosuoja-aineita valmistavaan Nordtreat-yhtiöön22.11.2022 09:15:00 EET | Tiedote
TAALERI BIOTEOLLISUUS LEHDISTÖTIEDOTE 22.11.2022 klo 9.15 Taalerin ensimmäinen bioteollisuusrahasto sijoittaa biopohjaisia palosuoja-aineita valmistavaan Nordtreat-yhtiöön Taalerin ensimmäinen bioteollisuuteen keskittyvä rahasto Taaleri Bioteollisuus I sijoittaa suomalaiseen biopohjaisia, ympäristöystävällisiä palosuoja-aineita valmistavaan Nordtreat-yhtiöön. Sijoituksella on tarkoitus vahvistaa Nordtreatin kasvua ja laajentumista. Vuonna 2015 perustettu Nordtreat valmistaa biopohjaisia palosuojakemikaaleja uusiutuvista raaka-aineista valmistettaviin rakennusmateriaaleihin. Yhtiö on kehittänyt ja kaupallistanut palosuoja-aineita erityisesti puurakentamiseen. Tuotteet perustuvat yhtiön kehittämään patentoituun palosuojausteknologiaan. Nordtreatin tuotteet korvaavat perinteisiä palosuoja-aineita, jotka sisältävät ihmisille ja ympäristölle haitallisia yhdisteitä kuten boorihappoa, formaldehydia ja ammoniakkia. Sijoitus Nordtreatiin on Taaleri Bioteollisuus I -rahaston toinen sijoitus. Rah
Taaleri’s first bioindustry fund invests in Colombier, a company producing ecological packaging16.11.2022 09:15:00 EET | Press release
TAALERI BIOINDUSTRY PRESS RELEASE 16 NOVEMBER 2022 AT 9:15 (EET) Taaleri’s first bioindustry fund invests in Colombier, a company producing ecological packaging Taaleri’s first bioindustry fund invests in Colombier, a company producing ecological packaging. The purpose of the investment is to expand Colombier Finland’s Ecological Packaging plant producing innovative packaging materials in Pyhtää, Finland. Colombier Finland is part of the international Colombier Group, which has 50 years of experience in paper and cardboard products. Today, the company offers its customers alternatives to plastic packaging. In addition to Finland, the group has subsidiaries in the Netherlands, Great Britain and Spain. The investment is Taaleri Bioindustry I Fund’s first investment. The fund invests in industrial-scale production facilities and companies that can accelerate the scaling of bioindustry production. Products can be, for example, bio- and recycled fibers, organic fertilizers, functional bioma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom